Номер части:
Журнал

VASCULAR SURGICAL ASPECT OF DIABETIC FOOT (42-45)



Науки и перечень статей вошедших в журнал:


Vascular surgical aspect of diabetic foot

Kostov O. H., PhD

Medical University — Plovdiv, Faculty of Social health, assistant

Summary

Diabetes continues to grow globally and to spend extremely large resources in the

health sector. One of the main factors for the incidence of diabetes is diabetic foot. Necrotic

changes in the latter are a complex problem. Ischemia, neuropathy and infection are the

three pathological components that lead to complications and often occur together as

etiological triad. Neuropathy and ischemia are initiating factors, most often in tandem as

neuroischemia until the infection is more a consequence. The role of peripheral arterial

disease in diabetic foot long underestimated since typical ischemic symptoms are less

common in diabetic patients with ischemia than in non-diabetic patients. Each necrosis

diabetic foot must wake suspected vascular disease until proven otherwise. Early referring

the patient to a specialist, noninvasive vascular testing, diagnosis and intervention are

crucial for the healing of necrosis and for the prevention of amputations, timing is crucial

because a window in which we can achieve wound healing and save limbs often can be

omitted.

Keywords: diabetic foot, neuroischemia, revascularization, amputation.

Diabetes mellitus and complication are becoming a major cause of morbidity and

mortality worldwide. This is a global problem that burdens significant health systems

and increased dramatically over the past two decades. For the first time Zmmet in

1992 used the term «diabetes epidemic», whereas as economic burden of disease on

society and purely human suffering from it. According to various epidemiological

studies cases of diabetes were about 30 million in 1985, 177 million in 2000, 285

million in 2010, their number is expected to grow to 360 million in 2030 to a mind-

boggling 642 million in 2040. Tap necrosis occurred in 25% of patients, so it should

be given more attention on prevention rather than treatment of ulcers, because five-

year mortality rates in diabetic patients who have suffered an amputation of lower limbs, are extremely high, making them more than just lung cancer.

The World Health Organization suggests that in 2030, diabetes will be the seventh in

 

a row cause of death globally. He one of the leading causes of loss of limb and each year

 

more than 1 million people undergo amputation. Approximately 80% of these amputations

are preceded by foot necrosis. Risk factors for ulcers include neuropathy, peripheral

 

arterial disease, foot deformity, restricted movements in ankle high plantar pressure of the

foot, small injuries, ulcers or previous amputations. At least a quarter of these ulcers will

 

heal and to 28% of them may need some form of amputation.

Diabetic peripheral neuropathy

In diabetic foot neuropathy is the main risk factor for the development of ulcers.

According to various sources, the spread between 16 and 66 percent, increasing the

duration of diabetes and poor glycemic control. Internationally recognized definition of

diabetic peripheral neuropathy is the presence of symptoms and / or signs of peripheral

 

nerve dysfunction in diabetic patients after exclusion of other causes.

Neuropathy presents as an inability to capture the temperature difference vibrations,

proprioception, pressure, and the most seriously hurt. Some patients have a form of

painful sensory neuropathy, which includes symptoms such as burning and tingling –

paraplegia. May be affected autonomous, motor and sensory functions of the nerves.

Although many manifestations of neuropathy may remain unrecognized by the patient, the

autonomy is perhaps the most neglected in the diabetic foot.

The located neuropathy can lead to increased secretion and increase the risk of fungal

infections. With the increased rigidity of the skin area parts of friction they become less flexible and thus develop lesions.

The reduction in motor function with neuropathy often affects the inner muscles of

the foot and cause joint instability and weakening of muscle groups. Over time, this

imbalance leads to flexible deformities that progressively become more rigid. The latter are

subjected to a greater pressure and conducive to formation of ulcers.

Screening for peripheral neuropathy includes test feeling of pressure; vibration;

measurement of vibration perception threshold; temperature test; test for pain and reflexes.

Obstructive arteriopathy in diabetics is more rapid progression and is usually

bilateral. Anatomical features are also typical — more commonly affected vessels below the

knee, the changes are symmetrical and multisegment as collaterals, which are generally

rare, can also be affected by the process. The nature of the lesions in different parts of the

arterial tree of the lower limb is also different. For arteries above the knee characteristic

eccentric intraluminar lesions, often with pronounced calcinosis, but there also soft,

unstable plaques rich lipid core, often with complications. For vessels below the knee is

typical media calcification by increasing it gradually leads to even blockage.

Although the strategy for prevention and treatment of diabetic foot is mainly

 

focused neuropathy, ischemia is the most important factor preventing healing. The

combined effect of peripheral neuropathy, and ischemia is defined as neuroischemia. The

maсroangiopathy and microvascular dysfunction violate perfusion of diabetic foot. Damage

to the regulation of blood flow to the opening of arteriovenous shunts and malfunction of

precapillary sphincters. Thus blood «bypasses» its recipient, namely capillaries.

Under the leadership of the European Society of Vascular Surgery for diabetic foot

ischemia and nevroishemia should be considered together, since both processes may need

revascularization.

The clinical picture is rarely symptomatic and most often characterized directly with

ischemic lesions or gangrene, which are typical for the later stages of the disease. Poor

prognosis in patients with diabetes and necrotic changes of the foot is due to other co-

factors such as anatomic distribution, infection, neuropathy, renal insufficiency and

involvement of other vascular beds — coronary and cerebrovascular. About 27 percent had

disease progression within the next five years, and 4% experiencing major amputation.

20% undergo another cardiovascular event (myocardial infarction or stroke).

The prognosis of diabetic patients with critical limb ischemia is even worse, with 30% of

them will undergo major amputation and 20% will die from another cardiovascular event

within a year.

Often patients with diabetes have associated renal insufficiency, which exacerbated

 

their forecast, as the disease is more severe and faster. Renal failure is a major risk factor

for ulcers and amputations in these patients, the risk of major amputation in dialysis

patients is 4.7 times higher than in non-dialysed.

The presence of peripheral pulses (a. Dorsalis pedis and a. Tibialis posterior) does

 

not exclude the possibility of ischemia of the foot (for example when occlusion on the

plangarnus arc), so it is necessary to use other methods for non-invasive examination of the

vascular system.

Foot-brachial index is the ratio of arterial tension level ankle to that of the level arm.

The test is simple and has a high predictive value for proof. The American Diabete

Association offers screening of all patients over 50 years and all insulin-dependent patients

of any age in the presence of other cardiovascular risk factors.

Transcutaneous oximetry is used in patients with ulcerations and gangrene, as for

 

normal value taken 50 mmHg.

Duplex ultrasonography allows morphological and functional analysis of the arterial tree.

Of the other non-invasive tests most commonly used are kompyutarnotomografskata

angiography and magnetic resonance angiography.

Primary invasive examination is digital subtraction angiography as used contrast

agent may also be a C02, especially in patients with renal insufficiency. When using

standard non-ionic contrast must not forget something very important — for patients treated

with metformin latter must be stopped due to the risk of lactic acidosis.

The main goal in treatment of the diabetic foot is the prevention of ulceration but in

the occurrence of such — quick and adequate treatment of the ulcers. Milestone in

addressing diabetic foot is a multidisciplinary approach. According to the strategy of the

National Institute for Health and Clinical Excellence team of specialists needed for patients

with diabetic foot, consists of a doctor, nurse, trainers, podiatrist, orthotic specialist

vascular surgeon, dermatologist , cardiologist, orthopedist, endocrinologist and

nutritionist. The American Diabetes Association concluded that the multidisciplinary team

reduces the level of amputations by 50-85% in patients with ulcers.

The main topic of the article is a vascular surgical strategy in the treatment of

diabetic foot, but will mention the other components of the therapy:

  1. Training the patient — it has been proven that 50% of the ulcers can be avoided with

 

proper training patients — avoiding risk factors,care for foot , regular checkups, etc.

  1. Strict control of blood sugar.
  2. Ability to relax the load — include in various orthopedic equipment and surgical

correction of deformity of the foot.

  1. Debridement in necrotic changes — surgical (sharp), mechanical (hydrotherapy, dry

dressing), autolysis, enzyme (streptokinase), biologically (sterile larvae).

  1. Dressings for diabetic ulcers — hydro colloids, hydrogels, foam, film dressings,

alginates, impregnated with silver.

  1. Others — hyperbaric oxygenation, electrostimulation therapy, negative pressure,

growth factors, skin grafts and other.

  1. Aggressive treatment of an infection.

The combination of ASA 100 mg and a low dose of rivaroxaban 2×2.5 mg

(COMPASS study) proves to be extremely suitable in patients with stable atherosclerotic

pathology.

The main goal in vascular surgical treatment of diabetic foot is the direct

revascularization and restore perfusion to the foot and toes. This is achieved through three

main methods: endovascular, open or hybrid surgery.

The success of vascular reconstruction of any kind depends on a free distal vessel

 

and stored plantar arch.

However, it is shown that up to 20% of patients with successful reconstructions do

not achieve healing of ulcers. This shows the complexity of the problem, especially microcirculations dysfunction. Therefore develop different methodologies for assessing

perfusion of the limb before and after revascularization, they can be differentiated patients

who would have really benefited from the intervention. So far the indications for

revascularization are:

  1. limit claudication and / or pain at rest
  2. trophic lesion that shows no signs of healing after one month of adequate treatment.

These techniques are mini-invasive, patients tolerate them lighter and has the

possibility of repetition of procedures. Naturally patency is significantly shorter than the

distal vascular bypass operations, which are considered the gold standard, but that patients

with many comorbidities are particularly suitable and friendly.

More common are cases where patients are referred for endovascular treatment after

unsuccessful surgery that. Endovascular treatment does not preclude open surgery, it must

still be applied by professionals who know or at least have seen distal bypass operations, in

order not to violate local, typical of anastomoses. It has been shown that open surgery is

much more difficult after a failed endovascular treatment, more frequent are

complications. The opposite is true with the same success and open surgery — you need to

keep the vessels of extremities despite being occluded, not ligated or resected since then

endovascular treatment is impossible.

Hybrid surgery using the best of both worlds — often composed of local or remote

arteries and endovascular balloon part with angioplastic and / or implantation of the stack.

Due to the nature of the disease open surgery relies mostly bypass operations to small

vessels of the lower leg and foot, so-called distal bypass. Main conduit in these operations is the autovein. Best results are achieved when three factors are present: adequate inflow,

good vein and stock ran off. When missing or damaged vein may be used a prosthesis or

combination of prosthesis / vein (composite bypass), but with significantly lower primary

patency than adequate in size autovena.

To determine which method of treatment to choose, it is important to consider four

main factors:

1. Clinical status of patients — age, comorbidity, life expectancy, type of anesthesia and others.

2.Evaluation of foot — good for a bypass, there infection, necrosis, affecting places anastomoses and others.

  1. Quality of venous conduit — assessment of all veins that can be used for graft.

4. Recipient vessel — size, calcification, theory of wounds, etc.

The goal of revascularization is to provide direct blood flow to the foot, possibly via

an anterior and / or posterior tibial artery, and for failure — and to the peroneal artery.

More serious is the situation when there is no recipient court, distal run off and

compromised microcirculation of the foot called desert foot. In such cases, we have four

options:

1. May try conservative treatment with prostaglandins and other vasodilators

(with unproved effect), the application of stem cells and other growth factors;

2.Arterial bypass reconstruction to shlateralen court — a labor-intensive operation with uncertain effect;

3.Venous arterializatsiya — the idea is very old — was first mentioned back in 1896 by Francois Franck M., and was applied in 1912 by Halstead and Vaughan to save limbs from gangrene.

In the past, the main problem was not so much surgical performance than the

destruction of venous valves. As is known valves increase in number from the proximal to distal direction of the limbs, each posterior tibial vein has valves 8-19, and each front tibial

or peroneal — 8-11. The aim is to provide blood flow to a level metatarsal and digital veins.

Known are two modern methods for such performance: endovascular and hybrid.

Endovascular treatment — the idea of ​​the invention is the following: used two

ultrasonic catheter (venous and arterial), and are positioned side by side at the distal

passable artery. Then both catheter made A-B fistula, which is covered with the standgraft. In this way we receive flow from the artery to the vein. It should dismantle the

valve apparatus endovascular valve and verification of the results. The results are more

than impressive with saving the limb in more than 71%.

Hybrid procedure — as yet do not have free with Lim Flow, another way of deep vein

arterialization is the hybrid approach. The technique consists of the following components:

performing operational A-B fistula through the bypass of the distal accessible artery (which may

 

be of the common femoral artery) to the deep crural vein. So created AB fistula will redirect blood

flow from the graft to the proximal veins. To be effective the procedure will be needed and

endovascular part — removing the valves in a distal direction.

Regardless of which of the two methods is used, deep vein arterialization gives

definitive solution for revascularization in these otherwise «doomed» amputation patients.

  1. Amputations — emergency or healing. The indications for amputation include

removing infected or gangrenous tissue and creating functional foot or stump to take the

boot or prosthesis respectively.

Conditional amputations are divided into small – fingers, metatarsus and large –

transtibial and transfemoral. Generally speaking, the more proximal amputation is, the

more complications. During the first 12 months after the amputation of a finger amputation

risk of new 22.8% ipsilateral and contralateral 3.5%. For 5 years, the risk becomes respectively 52.3% and 29.5%. There is no direct link between amputations and deaths, but

several studies have shown a very strong bond between them. Diabetic patients have a 55

percent higher risk of death after amputation than non-diabetics. The one-year mortality

after amputation of the finger 6.6% after amputation of the part of the sole 10,5% and

18,2% following a major amputation. The five-year mortality following a major amputation

is about 36%. The risk of amputation is determined most exactly with WIFI (Wound,

Ischemia, and Foot Infection) American Society of Vascular Surgery.

 

Conclusion

The incidence of diabetes increases significantly and diabetic foot and its

complications continue to be a major challenge to the health system and in particular to

vascular specialists. The neuroishemic diabetic foot is much more common than

believed. From a practical point of view, patients with ischemic clean and neuroishemic

pathology should be treated in the same way. Each wound in diabetic patient should be

viewed primarily as ischemic until proven otherwise. Any patients with these findings need

to be referred for consultation with a vascular specialist, because any delay can be

detrimental to the limb (the time is tissue!). Treatment of diabetic foot depends on two

factors: it is essential that the patient is sufficiently informed and involved with their

disease and treatment by specialists to be multidisciplinary. A combination of these two

factors chance diabetics to avoid or at least away significant complications of the diabetic

foot is very large. Preventing large and possibly a small amputation, we «save» largely

patient’s life.

References:

  1. Bostrom P. Wu.J. Jedrychowske MP, et al A PGCI-α-dependent myokine that drives brown-fat-like development of white fat ana thsmiogenesis. Nature. 2012;481:463-468
  2. Conway B, Mille RG. Costacou T. ei al. Adiposity and mortality in type 1 diabetes. Int Obes (Loud). 2009;33:796-805
  3. Costacou T, Evans RW, Orchard TJ. High-density lipoprotein cholesterol in diabetes: is higher always better? J Clin Lipidol. 2011:5:387-394.
  4. Costacon T, Ferrell RE, Orchard , J. Haptoglobin genotype: a determinant of cardiovascular complication risk in type 1 diabetes. Diabetes. 2008;57:1702-1706.
  5. Dabelea D, Kinney G, Snell-Bergeon JK. Hokanson JE. Eckel RH, Ehrlich J, Garg S, Наmmаn RF. Rewers M. Coronary Artery Calcification in Type i Diabetes Study. Effect of type I diabetes on the gender difference in coronary artery calcification: a role for insulin resistance» The Coronary Artery Calcification in Type 1 Diabetes (CACTI) Study. Diabetes. 2003;52(11):2833-2839.
  6. Darabian S, Backland JY. Cleary PA. Sheidaec N, Bebu I, Lachin JM. Bndoff MJ; DCCT/EDIC Research Group. Significance of epieardial and intrathoracic adipose tissue volume among type 1 diabetes patients in the DCCPEDIC: A pilot study. PLoS One. 2016: 11(7):e0159958.
  7. De Ferranti SD, de Boer IH, Fonseca V. et. al. Type 1 Diabetes Mellitus and Cardiovascular Disease: A Scientific State- ment From the American Hears Association and American Diabetes Association. Diabetes Care. 2014:37.2843-2863.
  8. Du Bose SM Flermann JM. Tamboriane WV, Beck RW, Dost A. DiMeglio LA, Schwab KO, Holl RW, Hofer SE Maahs DM; Type 1 Diabetes Exchange Clinic Network and Diabetes Prospective Follow-up Registry. Obesity in Youth with Type 1 Diabetes in Germany, Austria, and the United States. J Pediatr 2015 Sep;167(3):627-32.c 1-4.
  9. 9 Tapes D, Lao J, Carlssoo PO. Increased levels of irisin in people with long-standing Type 1 diabetes. Diabet Med. 2015 Sep;32(9): 1172-76.
Записи созданы 1350

Похожие записи

Начните вводить, то что вы ищите выше и нажмите кнопку Enter для поиска. Нажмите кнопку ESC для отмены.

Вернуться наверх